Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- DEI Compliance and Legal Counseling
- Dietary Supplement Litigation
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Experience
Our Team
Media
Events
Upcoming Events
- February 11-13, 2026
Past Events
Insights
Insights
- Firm AnnouncementsCorporate Transactional Attorney Kaci Hohmann Joins Epstein Becker Green in Portland2 minute read
- PublicationsRecalibrating Economic Crime Sentencing: The U.S. Sentencing Commission’s Proposed Reforms to Section 2B1.1 and What ...19 minute read
- BlogsSentencing Commission Seeks Public Input on Amendments to Fraud Sentencing Guidelines2 minute read
- Publications2026 Employment Law Changes: A Practical Guide for Oregon Employers9 minute read
- Publications2026 Washington Employment Law Update: Hiring Restrictions, Pay Transparency, Leave, and Workplace Safety16 minute read
- PublicationsAmazon's Third-Party Supplement Testing Mandate Explained8 minute read
- BlogsHealth Care Without the Hospital: ChatGPT Health and Claude Go Direct to Consumers13 minute read
- BlogsVideo: “Stay or Pay” Agreements, Developing Immigration News, EEOC Power Shift - Employment Law This Week4 minute read
- BlogsThe HTI-5 Proposed Rules: ASTP/ONC’s Cleanup and the Hard Work that Lies Ahead11 minute read
- Firm AnnouncementsTrial Attorney Daniel Dwyer Joins Epstein Becker Green in Boston, Strengthens Firm’s High-Stakes Business Litigation ...2 minute read
- Media CoverageKate Gallin Heffernan Featured in “3 Clinical Research Attorneys Talk 2026 Trends”3 minute read
- PublicationsHealth Systems Should Model Care Access Around How Consumers Actually Buy Care2 minute read
- PublicationsTelemental Health Laws: 2026 Overview11 minute read
- PublicationsFalse Claims Act Recoveries Reach Historic Highs in FY 2025: What It Signals for Health Care and Life Sciences Companies in ...7 minute read
- PublicationsThe Obituary of the US Childhood Immunization Schedule2 minute read
- BlogsOIG Limits Sign-On Bonuses to In-Home Family Caregivers8 minute read
- BlogsVideo: FMLA and FLSA Compliance in 2026—New DOL Opinion Letters and Emerging Risks - Employment Law This Week3 minute read
- PublicationsDOJ’s Use of False Claims Act to Challenge DEI Moves from Theory to Practice: What Businesses Need to Know11 minute read
- BlogsGoverning Health AI Development and Adoption: Insights from HHS’s Recently Announced Strategy to Promote AI in ...7 minute read
- Media CoverageAlexis Boaz Quoted in “Medical Price Transparency Rule Simplifies Data, Excludes Drugs”2 minute read
- PublicationsCMS’s MAHA ELEVATE Model: Integrating Whole‑Person Care into Original Medicare10 minute read
- Media CoveragePaul DeCamp Quoted in “DOL Clarifies How OT Factors into Bonus Payments”2 minute read
- Media CoverageMegan Robertson Quoted in “FDA Reissues Controversial CDS Final Guidance”4 minute read
- BlogsVideo: Employment Law in 2026: What to Expect - Employment Law This Week3 minute read
- BlogsThe DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Vendor”6 minute read
- BlogsStranger Things: New FDA Updates Flip Expectations for the Med Tech Industry in 2026 Upside Down5 minute read
- Media CoverageTrendspotting: Precision Diagnostics, Artificial Intelligence, Data Management, Collection2 minute read
- BlogsFDA Signals Flexibility on Placement of the DSHEA Disclaimer2 minute read
- Media CoveragePaul DeCamp Quoted in “Wage and Hour Regulatory Moves to Watch in 2026”2 minute read
- PublicationsCMS Seeks to Ban Hospitals from Providing Gender-Affirming Care to Minors17 minute read
- Media CoverageMarylana Saadeh Helou Quoted in "NIH Begins Review of Thousands of Delayed Research Proposals, Funding 135 on First Day ...2 minute read
- Media CoverageJack Wenik Quoted in “FDA Urges Supplement Industry to Push for Product Listing”2 minute read
- Media Coverage
Christine Burke Worthen Featured in AHLA’s Speaking of Health Law Podcast, “Health Care Claim Lifecycle and ...
2 minute read - PublicationsNew York Labor and Employment Legislation: Governor Hochul Acts on Four Bills Before Year-End9 minute read
- BlogsCMS Attempts to Use Medicare and Medicaid Conditions of Participation to Ban Hospitals from Providing Gender-Affirming ...8 minute read
- PublicationsWhat to Expect in 2026: New Jersey Employment Law Developments and Posting Mandates22 minute read
- Media CoverageRichard Hughes Quoted in “Chaos Could Be Coming for Children's Vaccines”2 minute read
- Media Coverage
Ashley Creech Featured in AHLA’s Speaking of Health Law Podcast, “Representing Physicians: Private Equity ...
2 minute read - Media CoverageMegan Robertson Quoted in “2025 Clinical Lab Space Bookended by Demise of FDA's LDT Rule, Abbott's $23B Exact Sciences ...2 minute read
- BlogsArtificial Intelligence Regulation at a Crossroads: The Trump Administration’s Preemption Push5 minute read
- BlogsVideo: Top Employment Law Changes of 2025 - Employment Law This Week3 minute read
- Media CoverageRichard Hughes Quoted in “Another Challenge to Vax-Mandate Carve-Outs”2 minute read
- Media CoveragePaul DeCamp Quoted in “DOL Shifted Focus from Worker-Friendly Rules in 2025”2 minute read
- Media CoverageMarylana Saadeh Helou Quoted in “NIH Specifies How Grant Reviewers Should Ensure Alignment with Trump Priorities” ...3 minute read
- PublicationsA MAHA Check-Up: Is the United States Getting Healthier?3 minute read
- PublicationsCalifornia Employers’ To-Do List to Prepare for 202618 minute read
- PublicationsNew Employee-Friendly Laws: What Illinois Employers Need to Know Entering 20267 minute read
- Media CoverageRichard Hughes Quoted in “RFK Jr. Wants to Radically Change Remedy for People Harmed by Vaccines”2 minute read
- Publications
How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation
4 minute read - BlogsSpilling Secrets Podcast: 2025 Non-Compete Year in Review2 minute read

